Vor Biopharma Inc.

VORNASDAQHealthcare● Active

$13.29

+$0.13(+0.99%)

Market Cap$91088411

P/E Ratio—

52W High$65.8

52W Low$3.62

Avg Volume1.0M

Open$13.60

Beta1.71

Insider Trades Ownership Employees

Vor Biopharma Inc. (VOR) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · VOR · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Vor Biopharma Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

VOR insider buying and selling by quarter

VOR insider selling · VOR insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

125.7M62.9M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · VOR ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

VOR executive sell shares · VOR board member insider trading · VOR insider trading SEC filing

Showing 83 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Apr 22, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	165,150	$15.77	$2.60M⚡	2,402,095	Form 4
Apr 17, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	458,411	$16.28	$7.46M⚡	2,739,208	Form 4
Apr 20, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	171,963	$15.77	$2.71M⚡	2,567,245	Form 4
Apr 13, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	530,610	$16.15	$8.57M⚡	3,404,998	Form 4
Apr 14, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	153,735	$15.97	$2.46M⚡	3,251,263	Form 4
Apr 15, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	53,644	$16.01	$859K	3,197,619	Form 4
Apr 8, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	353,242	$16.32	$5.76M⚡	4,202,499	Form 4
Apr 8, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	130,862	$16.91	$2.21M⚡	4,071,637	Form 4
Apr 9, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	135,201	$16.59	$2.24M⚡	3,936,436	Form 4
Apr 10, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	828	$15.75	$13K	3,935,608	Form 4
Apr 2, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	258,475	$18.23	$4.71M⚡	5,146,523	Form 4
Apr 2, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	1,525	$19.06	$29K	5,144,998	Form 4
Apr 6, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	537,754	$16.51	$8.88M⚡	4,607,244	Form 4
Apr 6, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	44,728	$17.31	$774K	4,562,516	Form 4
Apr 6, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Sale	6,775	$18.50	$125K	4,555,741	Form 4
Dec 18, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Award	4,625,346	$10.81	$50.00M⚡	5,404,998	Form 4
Dec 5, 2025	Mahatme Sandesh CFO	Other	694,137	—	—	0	Form 4
Oct 28, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	87,828	$27.10	$2.38M⚡	1,092,232	Form 4
Oct 28, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	36,483	$28.18	$1.03M⚡	1,055,749	Form 4
Oct 29, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	251,518	$25.22	$6.34M⚡	804,231	Form 4
Oct 30, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	24,579	$25.12	$617K	779,652	Form 4
Oct 23, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	76,880	$28.01	$2.15M⚡	1,324,346	Form 4
Oct 24, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	53,345	$28.01	$1.49M⚡	1,271,001	Form 4
Oct 27, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	90,941	$28.12	$2.56M⚡	1,180,060	Form 4
Oct 20, 2025	RA CAPITAL MANAGEMENT, L.P. Director	Sale	70,366	$29.63	$2.08M⚡	1,432,806	Form 4

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 22

165,150

Price

$15.77

Value

$2.60M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 17

458,411

Price

$16.28

Value

$7.46M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 20

171,963

Price

$15.77

Value

$2.71M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 13

530,610

Price

$16.15

Value

$8.57M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 14

153,735

Price

$15.97

Value

$2.46M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 15

53,644

Price

$16.01

Value

$859K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 8

353,242

Price

$16.32

Value

$5.76M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 8

130,862

Price

$16.91

Value

$2.21M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 9

135,201

Price

$16.59

Value

$2.24M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 10

828

Price

$15.75

Value

$13K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 2

258,475

Price

$18.23

Value

$4.71M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 2

1,525

Price

$19.06

Value

$29K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 6

537,754

Price

$16.51

Value

$8.88M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 6

44,728

Price

$17.31

Value

$774K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Apr 6

6,775

Price

$18.50

Value

$125K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Award

Date

Dec 18

4,625,346

Price

$10.81

Value

$50.00M ⚡

View Form 4 on SEC.gov

Mahatme Sandesh

CFO

Other

Date

Dec 5

694,137

Price

—

Value

—

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 28

87,828

Price

$27.10

Value

$2.38M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 28

36,483

Price

$28.18

Value

$1.03M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 29

251,518

Price

$25.22

Value

$6.34M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 30

24,579

Price

$25.12

Value

$617K

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 23

76,880

Price

$28.01

Value

$2.15M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 24

53,345

Price

$28.01

Value

$1.49M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 27

90,941

Price

$28.12

Value

$2.56M ⚡

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Sale

Date

Oct 20

70,366

Price

$29.63

Value

$2.08M ⚡

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About VOR insider trading

VOR insider trades

Vor Biopharma Inc. (VOR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including RA CAPITAL MANAGEMENT, L.P. (Director), Reprogrammed Interchange LLC (10 percent owner), Mahatme Sandesh (CFO). Over the past 12 months, 3 insiders have filed transactions with the SEC. VOR insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Vor Biopharma Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

VOR insider trading · 5 questions

The insiders of Vor Biopharma Inc. (VOR) include executives and directors such as RA CAPITAL MANAGEMENT, L.P. (Director), Reprogrammed Interchange LLC (10 percent owner), Mahatme Sandesh (CFO), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

VOR board member insider tradingwho are VOR insidersVOR insider rosterVor Biopharma Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026